App-Quantinova.ai

Circulating tumor cell as a predictive marker for immunotherapy in advnaced non-small cell lung cancer

Cheol-Kyu Park - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

Atezolizumab

Rapid microfluidic isolation and detection of circulating tumor cells/clusters with zero sample preparation

Jian Zhou - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Can breast cancer cells be distinguished from blood cells by mechanical parameters? A label-free CTC detection approach

Ivonne Nel - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Breast cancer

N/A

ADGRG1 promotes tumorigenesis, invasion/migration, and cell-cell adhesion in triple-negative breast cancer cells

Raksha Bhat - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Triple-negative breast cancer

N/A

Design, optimization, and validation of multiplex immunofluorescence assay for detecting biomarker expression on circulating tumor cells in breast cancer

Tanya Kumar - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

B cell lymphomas

N/A

Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis

Aline Vanwynsberghe - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

CTCs positively correlate clinical manifestations in Indian oral cancer patients

Jayant Khandare - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Oral cancer

N/A

Non-invasive profiling of advanced prostate cancer via multi-parametric liquid biopsy and radiomics

Gareth J. Morrison - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

Genome-wide loss-of-heterozygosity calling from low-pass sequencing of ligation-mediated whole genome amplified DNA in single tumor cells

Alberto Ferrarini - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Multiple Myeloma

N/A

An initial analysis

Audrey H. Choi - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

CapioCyte™ technology for efficient capture and downstream analysis of circulating tumor cells from renal cell carcinoma

Jiyoon Bu - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

N/A

Tumor-derived Extracellular Vesicles (EVs) expressing TGFb as potential biomarkers for anti-TGFb antibody activity and drug activity in liquid biopsy

Manoel Nunes - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The perfused 3DKUBE™ rare tumor assay models in vivo drug response

Melissa Millard - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Dermatofibrosarcoma protuberans

N/A

Real-time serial monitoring of liquid biopsies allows earlier detection of treatment responses and relapse for metastatic esophageal squamous cell carcinoma

Josephine M. KO - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Esophageal squamous carcinoma cell

TP53

Identification and clinical value of the circulating tumor cells (CTCs) in the colorectal cancer

Faysal-Bin Hamid - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Standardization and automation of volume reduction procedure for circulating tumor cells and rare cell workflows with VRNxT technology

Mariano Di Trapani - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

A pilot study using diagnostic leukapheresis followed by the NanoString low RNA input nCounter assay

Liang Dong - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Longitudinal investigation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab

Yasuhiro Koh - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

Nivolumab

Analytic validation of an assay to detect androgen receptor splice variant ARv7 protein expression on circulating tumor cells from prostate cancer patients

Daniel Campton - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Androgen Tear

Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer

JASMINE J. WANG - American Association for Cancer Research (AACR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Enzalutamide

Filters

1671 Abstracts